2024 INSIGHT INTO INSULIN GLARGINE BIOSIMILARS

Insulin glargine, a long-acting insulin analog, is critical in managing diabetes, providing consistent glucose control for up to 24 hours. With the global rise in diabetes cases, insulin glargine biosimilars have become an affordable alternative to branded treatments like Sanofi's Lantus, helping to reduce the financial